What is Tekla Healthcare Opportunities Fund Median PS Value?
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
THQ's Price-to-Median-PS-Value is not ranked *
in the Asset Management industry.
Industry Median: 0.97 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Tekla Healthcare Opportunities Fund Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Tekla Healthcare Opportunities Fund Median PS Value Chart
Competitive Comparison of Tekla Healthcare Opportunities Fund's Median PS Value
For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tekla Healthcare Opportunities Fund's Price-to-Median-PS-Value Distribution in the Asset Management Industry
For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Tekla Healthcare Opportunities Fund's Price-to-Median-PS-Value falls into.
Tekla Healthcare Opportunities Fund Median PS Value Calculation
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tekla Healthcare Opportunities Fund's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.335.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla Healthcare Opportunities Fund (NYSE:THQ) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Tekla Healthcare Opportunities Fund's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
20.14
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla Healthcare Opportunities Fund Median PS Value Related Terms
Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Tekla Healthcare Opportunities Fund (Tekla Healthcare Opportunities Fund) Business Description
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests in securities of public and private companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
THQ has been successfully added to your 